Quanterix is a company that develops and markets ultra-sensitive digital immunoassay platforms. Their Simoa (Single Molecule Array) technology allows for the detection and quantification of proteins at much lower concentrations than traditional immunoassays. This is commonly used in research and diagnostics to detect biomarkers for various diseases, including neurological disorders, infectious diseases, and oncology, enabling earlier and more precise disease detection and monitoring.
This tech insight summary was produced by Sumble. We provide rich account intelligence data.
On our web app, we make a lot of our data available for browsing at no cost.
We have two paid products, Sumble Signals and Sumble Enrich, that integrate with your internal sales systems.